Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
  • In Press
Advanced
Search Within

Reuben Benjamin

  • Home
  • Works
  • Groups
  1. "Isabelle Riviere"
Formats
  1. Meeting Abstract (1)
Groups
  1. Center for Hematologic Malignancies (1)
  2. Department of Medicine (1)
  3. GSK Faculty (1)
  4. Hematologic Malignancies Research (1)
  5. Hematologic Malignancies, Division of (1)
  6. Molecular Pharmacology and Chemistry Program Faculty (1)
  1. Center for Hematologic Malignancies (1)
  2. Department of Medicine (1)
  3. GSK Faculty (1)
  4. Hematologic Malignancies Research (1)
  5. Hematologic Malignancies, Division of (1)
  6. Molecular Pharmacology and Chemistry Program Faculty (1)
  7. Sloan Kettering Institute Faculty (1)

More Groups

Fewer Groups

People
  1. Gertrude Gunset (1)
  2. Isabelle Riviere (1)
  3. Jason Plotkin (1)
  4. Maud Condomines (1)
  5. Michel Sadelain (1)
Years
  1. 2012 (1)
Publications
  1. Molecular Therapy (1)
Publishers
  1. Nature Publishing Group (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Attenuated CTLA-4 inhibition in CD19-targeted T cells expressing a second-generation CD28-based chimeric antigen receptor
    Meeting Abstract

    Condomines, M.; Arnasson, J.; Benjamin, R.; Plotkin, J.; Gunset, G.; Riviere, I.; Sadelain, M.
    Molecular Therapy (2012)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2022 Memorial Sloan Kettering Cancer Center Library